Nitroxyl (HNO) Releasing Therapeutics The National Cancer Institute's Cancer and Inflammation Program is seeking statements of capability or interest from parties interested in licensing therapeutic agents that generate Nitroxyl (HNO) in physiological media. Therapeutics
